Details for New Drug Application (NDA): 211033
✉ Email this page to a colleague
The generic ingredient in CLONAZEPAM is clonazepam. There are ten drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clonazepam profile page.
Summary for 211033
Tradename: | CLONAZEPAM |
Applicant: | Alembic |
Ingredient: | clonazepam |
Patents: | 0 |
Suppliers and Packaging for NDA: 211033
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLONAZEPAM | clonazepam | TABLET, ORALLY DISINTEGRATING;ORAL | 211033 | ANDA | Alembic Pharmaceuticals Limited | 46708-364 | 46708-364-06 | 60 BLISTER PACK in 1 CARTON (46708-364-06) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
CLONAZEPAM | clonazepam | TABLET, ORALLY DISINTEGRATING;ORAL | 211033 | ANDA | Alembic Pharmaceuticals Limited | 46708-365 | 46708-365-06 | 60 BLISTER PACK in 1 CARTON (46708-365-06) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 0.125MG | ||||
Approval Date: | Jun 28, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 0.25MG | ||||
Approval Date: | Jun 28, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 0.5MG | ||||
Approval Date: | Jun 28, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription